` NAN (Nanosonics Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

NAN
vs
S&P/ASX 300

Over the past 12 months, NAN has underperformed S&P/ASX 300, delivering a return of -25% compared to the S&P/ASX 300's 11% growth.

Stocks Performance
NAN vs S&P/ASX 300

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NAN vs S&P/ASX 300

Loading
NAN
S&P/ASX 300
Difference

Performance By Year
NAN vs S&P/ASX 300

Loading
NAN
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Nanosonics Ltd vs Peers

S&P/ASX 300
NAN
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Nanosonics Ltd
Glance View

Market Cap
946.9m AUD
Industry
Health Care

Nanosonics Ltd. engages in the research, development, and commercialization of infection control and decontamination products and related technologies. The company is headquartered in Sydney, New South Wales and currently employs 339 full-time employees. The company went IPO on 2007-05-17. The firm's principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. The firm is focused on research, development and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generates sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. The firm's products include trophon2, Nanosonics Auditpro, and trophon electron paramagnetic resonance (ERP). trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics Auditpro provides real-time intelligence on ultrasound probes, operators, and infection control events to manage infection prevention practices across organizations.

NAN Intrinsic Value
2.429 AUD
Overvaluation 22%
Intrinsic Value
Price
Back to Top